글로벌 박테리아 감염 질환 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모                              

박테리아에 의한 감염은 인간의 건강에 상당한 영향을 미칩니다. 이 질병은 신체의 어느 곳에서나 발생할 수 있으며, 유기체 또는 박테리아의 존재에 대한 신체의 반응에 의해 생성됩니다. 박테리아는 공기, 물, 음식 및 살아있는 매개체를 통해 인간에게 퍼집니다. 접촉, 공기 중, 물방울, 매개체 및 차량 전파는 박테리아 전파의 가장 일반적인 메커니즘입니다. 예방 조치를 취하면 이환율과 사망률이 극적으로 감소합니다. 물 처리, 동물 및 인간 면역, 개인 위생 및 안전한 성생활은 이러한 접근 방식의 예입니다. 항생제 내성은 점점 더 우려되는 문제이며, 항생제를 신중하게 사용해야 합니다.

Data Bridge Market Research는 박테리아 감염 질환 시장이 2021년에 720억 달러 규모였으며 2029년까지 1,382억 8,000만 달러에 도달할 것으로 예상하고 2022년부터 2029년까지의 예측 기간 동안 8.50%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

박테리아 감염은 위험한 박테리아 균주가 신체 위나 내부에서 증식할 때 발생합니다. 박테리아는 인체의 모든 부분을 감염시킬 수 있는 능력이 있습니다. 폐렴 , 수막염 및 식중독은 위험한 박테리아가 일으킬 수 있는 질병 중 일부에 불과합니다. 박테리아는 구형(구균), 막대형(간균), 나선형(나선균)일 수 있습니다. 그람 염색, 항생제 감수성 검사를 통한 박테리아 배양 및 유전자 분석과 같은 기타 기술을 사용하여 박테리아 균주를 식별하고 치료에 도움을 줍니다. 박테리아 감염은 인후, 폐, 피부, 장 및 기타 신체 부위를 손상시킬 수 있습니다. 많은 것이 사소하지만 다른 것은 심각합니다. 항생제는 대부분의 박테리아 질병을 효과적으로 치료할 수 있습니다. 그들은 세균을 파괴하거나 성장을 방지합니다. 이것은 면역 체계가 세균과 싸우는 능력을 향상시킵니다.

박테리아 감염 질병 시장 역학

운전자

• 세균 감염 질병 의 유병률 증가

박테리아 감염 질환의 유병률이 증가함에 따라 시장 성장률이 확대될 것으로 예상됩니다. 하부 호흡기 감염, 폐렴, 말라리아, 결핵을 포함한 감염성 질환도 시장 확장을 주도하고 있습니다. 질병 부담이 증가함에 따라 정부와 비정부 기관은 연구 개발 활동에 투자하고 새로운 항생제 개발을 가속화하고 승인 절차와 연구 자금 조달을 가속화하기 위한 지원 규제 조치를 취해야 합니다. 예를 들어, BARDA는 정부와 협력하여 여러 회사가 혁신적인 감염성 질환 치료제를 개발하도록 지원했습니다.

• 의료 인프라에 대한 투자 증가

Another significant factor influencing the growth rate of bacterial infection diseases market is the rising healthcare expenditure which helps in improving its infrastructure. Government policies all around the world are focusing on strengthening the healthcare system by boosting healthcare budgets and creating consistent policies. Governments all throughout the world are supporting the healthcare system. The world's healthcare system has benefited from increased healthcare spending. Developed economies, such as the U.S., U.K., Germany, and Canada, invest substantial money in healthcare. China, Korea, India, and Korea are among the growing economies that are expanding their healthcare spending.

Furthermore, a surging number of government initiatives to spread awareness and sedentary lifestyle will result in the expansion of bacterial infection diseases market. Along with this, rising level of disposable income and increased exposure to chemicals and pollutants will enhance the market's growth rate.

Opportunities

• Rise in R&D activities  

The market's growth is fueled by a growing number of research activities to develop innovative treatments to treat infectious disorders. This will provide beneficial opportunities for the bacterial infection diseases market growth. According to Pew Charitable Trust around 41 promising compounds were being researched to treat serious bacterial infections in December 2019. 17 of the 41 investigational medications are in the third phase of clinical trials or have filed a New Drug Application for approval, and are anticipated to be commercialized within the forecast period of 2022-2029. Four new antibiotics were approved by the US Food and Drug Administration in the second half of 2019.

Moreover, the market's growth is fueled by investment to develop advanced technologies and increase the number of emerging markets. These factors will provide beneficial opportunities for the bacterial infection diseases market growth.

Restraints/Challenges

On the other hand, the high cost associated with the treatment will obstruct the growth rate of bacterial infection diseases market during the forecast period of 2022-2029. The patent expiry of branded drugs and introduction of generic drugs will challenge the bacterial infection diseases market. Additionally, lack of healthcare infrastructure in developing economies and the dearth of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This bacterial infection diseases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bacterial infection diseases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Bacterial infection diseases market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. 

COVID-19 Impact on Bacterial Infection Diseases Market

In order to contain the coronavirus outbreak, most of the world's main nations were compelled to go into lockdown. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. As a result of this predicament, most pharmaceutical companies worldwide are focusing on preserving their commerce and cash flow rather than investing in product development. Key players in the healthcare sector were also having difficulty running their plants and working at full capacity in order to meet their production targets. However, the bacterial infection diseases market is likely to improve as respective government bodies lifted the enforced lockdown restrictions. Various sectors are anticipated to rebound quickly post COVID-19 pandemic due to the wide number of applications they serve. As a result, the market is projected to stabilize in the future.

Global Bacterial Infection Diseases Market Scope

The bacterial infection diseases market is segmented on the basis of types, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Bacterial Skin Infections
• Foodborne Bacterial Infections
• Sexually Transmitted Infections
• Others

Treatment

• Medication
• B-lactam
• Quinolones
• Macrolides
• Tetracyclines
• Others
• Therapy
• Others

Diagnosis

• Blood Tests
• Imaging Studies
• Others

Route of Administration

• Oral
• Topical
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Bacterial Infection Diseases Market Regional Analysis/Insights

The bacterial infection diseases market is analysed and market size insights and trends are provided by country, types, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the bacterial infection diseases market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the bacterial infection diseases market because of the rising healthcare expenditure and increasing patient population in this region. Additionally, the growing focus of major key players in research and development activities will further propel the market’s growth rate.

Asia-Pacific is expected to be the fastest-growing region during the forecast period of 2022-2029 due to increasing prevalence of bacterial infections and large number of generic manufacturer in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Bacterial Infection Diseases Market Share Analysis

The bacterial infection diseases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bacterial infection diseases market.

박테리아 감염 질환 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 엘리 릴리 앤드 컴퍼니(미국)
• 아스트라제네카(영국)
• 노바티스 AG(스위스)
• 존슨앤존슨 프라이빗 리미티드(미국)
• Teva Pharmaceutical Industries Ltd. (아일랜드)
• 머크앤코(미국)
• 알러간(아일랜드)
• Bausch Health Companies Inc. (캐나다)
• 애벗(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 사노피(프랑스)
• 머크 KGaA(독일)
• Sun Pharmaceutical Industries Ltd. (인도)
• 엔도 인터내셔널 주식회사(아일랜드)
• Apotex Inc. (캐나다)
• Amneal Pharmaceuticals LLC. (미국)
• Fresenius Kabi AG(독일)
• Torrent Pharmaceuticals Ltd. (인도)

SKU-53444